BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19328226)

  • 1. Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.
    Turpeinen M; Tolonen A; Chesne C; Guillouzo A; Uusitalo J; Pelkonen O
    Toxicol In Vitro; 2009 Jun; 23(4):748-53. PubMed ID: 19328226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
    Robertson P; DeCory HH; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The olivacine derivative s 16020 (9-hydroxy-5,6-dimethyl-N-[2-(dimethylamino)ethyl)-6H-pyrido(4,3-B)-carbazole-1-carboxamide) induces CYP1A and its own metabolism in human hepatocytes in primary culture.
    Pichard-Garcia L; Weaver RJ; Eckett N; Scarfe G; Fabre JM; Lucas C; Maurel P
    Drug Metab Dispos; 2004 Jan; 32(1):80-8. PubMed ID: 14709624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
    Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
    Westerink WM; Schoonen WG
    Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
    Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
    Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes.
    Ghosal A; Hapangama N; Yuan Y; Lu X; Horne D; Patrick JE; Zbaida S
    Biopharm Drug Dispos; 2003 Dec; 24(9):375-84. PubMed ID: 14689466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential maintenance of cytochrome P450 enzymes in cultured precision-cut human liver slices.
    Renwick AB; Watts PS; Edwards RJ; Barton PT; Guyonnet I; Price RJ; Tredger JM; Pelkonen O; Boobis AR; Lake BG
    Drug Metab Dispos; 2000 Oct; 28(10):1202-9. PubMed ID: 10997941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: comparison with surgical liver biopsies.
    Donato MT; Serralta A; Jiménez N; Pérez G; Castell JV; Mir J; Gómez-Lechón MJ
    Drug Metab Dispos; 2005 Jan; 33(1):108-14. PubMed ID: 15448115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting.
    Jover R; Bort R; Gómez-Lechón MJ; Castell JV
    Hepatology; 2001 Mar; 33(3):668-75. PubMed ID: 11230748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.
    McGinnity DF; Berry AJ; Kenny JR; Grime K; Riley RJ
    Drug Metab Dispos; 2006 Aug; 34(8):1291-300. PubMed ID: 16679385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
    Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Pyrethrins on cytochrome P450 forms in cultured rat and human hepatocytes.
    Price RJ; Giddings AM; Scott MP; Walters DG; Capen CC; Osimitz TG; Lake BG
    Toxicology; 2008 Jan; 243(1-2):84-95. PubMed ID: 18022748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells.
    Ek M; Söderdahl T; Küppers-Munther B; Edsbagge J; Andersson TB; Björquist P; Cotgreave I; Jernström B; Ingelman-Sundberg M; Johansson I
    Biochem Pharmacol; 2007 Aug; 74(3):496-503. PubMed ID: 17568565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
    Zhang JG; Dehal SS; Ho T; Johnson J; Chandler C; Blanchard AP; Clark RJ; Crespi CL; Stresser DM; Wong J
    Drug Metab Dispos; 2006 May; 34(5):734-7. PubMed ID: 16501008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.